At 11.7% CAGR, the Asia Pacific Antimicrobial surgical suture market is Projected to be Worth US$ 124.73 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the Asia Pacific antimicrobial surgical suture market was valued at US$ 51.68 in 2023 and is expected to reach US$ 124.73 million by 2031, registering a CAGR of 11.7% from 2024 to 2031. Strategic initiatives in antimicrobial surgical suture and smart antimicrobial sutures are among the critical factors attributed to the Asia Pacific antimicrobial surgical suture market expansion.

Antimicrobial surgical suture holds tremendous potential in the surgical treatments of various ailments owing to their ability to prevent surgical site infections, which are common and one of the common causes of morbidity in postoperative setups. A few of the recent strategic initiatives by antimicrobial surgical suture market players are mentioned below.

• In July 2022, Dolphin Sutures launched its Antibacterials range of antibacterial sutures containing Triclosan coating, which is a known broad-spectrum antibacterial and antifungal agent.
• In May 2022, Ethicon, Inc., a Johnson & Johnson Company, filed 510(K) to receive premarket approval for PDS Plus Antibacterial (Polydioxanone) Sterile Synthetic Absorbable Surgical Suture.

Thus, continuous advancements in surgical sutures with product developments, innovations, product launches, product approvals, mergers, acquisitions, and partnerships are expected to present significant growth opportunities in the antimicrobial surgical suture market growth in the coming years.

On the contrary, non-invasive alternatives to stitches hampers the growth of Asia Pacific antimicrobial surgical suture market.

Based on type, the Asia Pacific antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture segment held 70.0% share of the Asia Pacific antimicrobial surgical suture market in 2023, amassing US$ 36.18 million. It is projected to garner US$ 88.42 million by 2031 to expand at 11.9% CAGR during 2024–2031.

By raw materials, the Asia Pacific antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held 59.3% share of the Asia Pacific antimicrobial surgical suture market in 2023, amassing US$ 30.62 million. It is projected to garner US$ 74.14 million by 2031 to expand at 11.8% CAGR during 2024–2031.

By application, the Asia Pacific antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held a 33.8% share of the Asia Pacific antimicrobial surgical suture market in 2023, amassing US$ 17.47 million. It is projected to garner US$ 41.13 million by 2031 to expand at 11.4% CAGR during 2024–2031.

By end user, the Asia Pacific antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals surgery segment held 46.6% share of the Asia Pacific antimicrobial surgical suture market in 2023, amassing US$ 24.06 million. It is projected to garner US$ 57.01 million by 2031 to expand at 11.5% CAGR during 2024–2031.

Based on country, the Asia Pacific antimicrobial surgical suture market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held 28.4% share of Asia Pacific antimicrobial surgical suture market in 2023, amassing US$ 14.66 million. It is projected to garner US$ 33.99 million by 2031 to expand at 11.2% CAGR during 2024–2031.

Key players operating in the Asia Pacific antimicrobial surgical suture market are Advanced MedTech Solutions Pvt. Ltd.; Futura Surgicare Pvt Ltd (Dolphin Sutures); Healthium Medtech Limited; Internacional Farmacéutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; and TI Medical, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com